ULTIBRO

ਉਤਪਾਦ ਝਲਕ

About ULTIBRO

ULTIBRO is a medication containing the active ingredient indacaterol maleate. Indacaterol is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis. It needs to be taken only once a day, unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD). It is delivered through a dry powder inhaler.

Key Benefits & Uses

• Used for: Indacaterol is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis
• Used for: It needs to be taken only once a day, unlike the related drugs formoterol and salmeterol
• Used for: It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD)

Active Ingredient & Action

indacaterol maleate, the active ingredient in ULTIBRO, is the pharmacologically active substance of this product. Its clinical use follows the authorised labelling for indacaterol maleate-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking ULTIBRO. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use ULTIBRO for extended periods without medical advice.